BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6110537)

  • 1. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic effect of 2-deoxy-D-glucose on plasma glucagon levels in conscious rats.
    Haito K; Takeda A; Kagawa S; Shimizu S; Matsuoka A
    Horm Metab Res; 1984 Dec; 16 Suppl 1():110-3. PubMed ID: 6398250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of pancreatic polypeptide and glucagon secretion by 2-deoxy-D-glucose in man: evidence for cholinergic mediation.
    Hedo JA; Villanueva ML; Marco J
    J Clin Endocrinol Metab; 1978 Aug; 47(2):366-71. PubMed ID: 400718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central control of peripheral circulating somatostatin in dogs: effect of 2-deoxyglucose.
    Ipp E; Piran U; Richter H; Garberoglio C; Moossa A; Rubenstein AH
    Am J Physiol; 1982 Sep; 243(3):E213-6. PubMed ID: 6126123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K; Unger RH
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of plasma somatostatin-like immunoreactivity to the administration of alloxan in dogs.
    Schusdziarra V; Harris V; Unger R
    Horm Metab Res; 1979 Aug; 11(8):457-9. PubMed ID: 499995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sham feeding, bethanechol, and bombesin on somatostatin release in dogs.
    De Graef J; Woussen-Colle MC
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G1-7. PubMed ID: 2857065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of gastric acid on circulating somatostatin-14 and -28 released after insulin-induced hypoglycemia in conscious dogs.
    Greenberg GR; Pokol-Daniel S; Fung L
    Endocrinology; 1992 Sep; 131(3):1527-33. PubMed ID: 1354604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infusion of graded concentrations of somatostatin in man: pharmacokinetics and differential inhibitory effects on pituitary and islet hormones.
    Skamene A; Patel YC
    Clin Endocrinol (Oxf); 1984 May; 20(5):555-64. PubMed ID: 6146413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
    Taborsky GJ; Ensinck JW
    J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect and mechanism of vagal nerve stimulation on somatostatin secretion in dogs.
    Ahrén B; Paquette TL; Taborsky GJ
    Am J Physiol; 1986 Feb; 250(2 Pt 1):E212-7. PubMed ID: 2869692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of somatostatin following a test meal in dogs. Initial atropine resistant vagally mediated decrease of somatostatin levels and increase of gastrin and insulin levels.
    Uvnäs-Moberg K; Andersson B; Posloncec B
    Acta Physiol Scand; 1982 Feb; 114(2):253-9. PubMed ID: 6127867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracellular glucopenia on pulsatile growth hormone secretion: mediation in part by somatostatin.
    Painson JC; Tannenbaum GS
    Endocrinology; 1985 Sep; 117(3):1132-8. PubMed ID: 2862015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomic nervous system control of glucagon secretion during neuroglucopenia.
    Asplin CM; Werner PL; Halter JB; Hollander PM; Palmer JP
    Endocrinology; 1983 May; 112(5):1585-9. PubMed ID: 6339209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of peptide YY on insulin release stimulated by 2-deoxyglucose and neuropeptides in dogs.
    Guo YS; Singh P; DeBouno JF; Thompson JC
    Pancreas; 1988; 3(2):128-34. PubMed ID: 3287367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of 2-deoxy-glucose-induced insulin secretion in the mouse.
    Karlsson S; Bood M; Ahrén B
    J Auton Pharmacol; 1987 Jun; 7(2):135-44. PubMed ID: 3308892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.
    Wasada T; Howard B; Dobbs RE; Unger RH
    J Clin Invest; 1980 Sep; 66(3):511-6. PubMed ID: 6105166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients.
    Schusdziarra V; Harris V; Arimura A; Unger RH
    Endocrinology; 1979 Jun; 104(6):1705-8. PubMed ID: 446390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neither adrenergic nor cholinergic antagonists in the central nervous system affect 2-deoxy-D-glucose(2-DG)-induced hyperglycemia.
    Iguchi A; Gotoh M; Matsunaga H; Yatomi A; Uemura K; Miura H; Kunoh Y; Tamagawa T; Sakamoto N
    Brain Res; 1990 Mar; 510(2):321-5. PubMed ID: 1970507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.